-
Mylan's generic leukemia drug gets green light from FDA
PITTSBURGH The Food and Drug Administration has approved a generic chemotherapy drug made by Mylan.
The Pittsburgh-based drug maker said Monday that it had received approval for the injected drug fludarabine phosphate in the 25-mg-per-mL strength. The FDA determined the drug to be therapeutically equivalent to Teva Parenteral’s fludarabine phosphate.
-
Mylan's generic Wellbutrin XL enters market
PITTSBURGH Mylan has launched a generic version of a common antidepressant, the company said Friday.
Mylan announced the launch of bupropion hydrochloride extended-release tablets in the 150-mg and 300-mg strengths, a once-daily treatment for depression.
The drug is a generic version of GlaxoSmithKline’s Wellbutrin XL. Various versions of the drug had sales of around $752 million during the 12-month period ended in June, according to IMS Health.